Skip to content

PharmaPark Production OÜ

Registry code (registrikood) 16729463Private limited company (Osaühing)VAT EE102612846Activity (EMTAK 21201): Ravimpreparaatide tootmineActive

Tallinn, Harju County · Financial data: annual reports up to 2025; tax data up to 2026 Q3

Revenue (2025)
€5.7M
▲ 294.9% vs 2024
Profit before tax (2025)
-€5.2M
Employees, FTE (2025)
63
State taxes paid, last 4 quarters
€337k

Revenue, profit and employees, 2023–2025

€2.1k2023€1.4M2024€5.7M2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2023€2,052-€128,283-€129,978-€127,4783
2024€1,440,758-€3,705,687-€3,778,347-€3,905,82536
2025€5,689,731-€5,002,447-€5,171,670€15,575,44563

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2023€1,264€87,303€214,781—-€127,478
2024€2,060€3,953,224€7,859,049€0-€3,905,825
2025€724,310€25,102,911€9,271,506€255,960€15,575,445

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2023 Q2——€04
2023 Q3€7,348€10,068€06
2023 Q4€9,864€10,960€59,05611
2024 Q1€37,047€41,380€2,49020
2024 Q2€34,417€103,588€276,21629
2024 Q3€0€137,811€616,26152
2024 Q4€0€183,952€2,465,12159
2025 Q1€0€220,075€1,321,16564
2025 Q2€0€236,612€1,090,49662
2025 Q3€0€247,569€593,01159
2025 Q4€0€247,269€2,567,82079
2026 Q1€0€264,838€5,512,39894
2026 Q2€0€300,360€7,004,49798
2026 Q3€337,392€332,772€7,704,571114

Source: EMTA quarterly published data, as of 10 October 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 January 2025–31 December 2025), PharmaPark Production OÜ reported revenue of €5,689,731.

The company recorded a net loss of €5,171,670 in the 2025 financial year.

Revenue increased by 294.9% from €1,440,758 in 2024 to €5,689,731 in 2025.

Revenue grew at a compound annual rate of 5165.7% between 2023 and 2025.

Equity accounted for 62.0% of total assets of €25,102,911 at the end of the 2025 reporting period.

With 63 full-time-equivalent employees in 2025, revenue per employee was €90,313.

Across the 4 most recent quarters declared to EMTA, up to Q3 2026, PharmaPark Production OÜ reported €22,789,286 in turnover.

EMTA recorded 114 employees for the quarter ending Q3 2026, compared with 63 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-11-16. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.